Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malaria
Saved in:
Main Authors: | Steffen Borrmann, Tim Peto, Robert W. Snow, Win Gutteridge, Nicholas J. White |
---|---|
Other Authors: | Kenya Medical Research Institute |
Format: | Review |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/19498 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Some considerations in the design and interpretation of antimalarial drug trials in uncomplicated falciparum malaria
by: Kasia Stepniewska, et al.
Published: (2018) -
Population pharmacokinetics of quinine in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda
by: Frank Kloprogge, et al.
Published: (2018) -
Emergence and clearance of gametocytes in uncomplicated Plasmodium falciparum malaria
by: Watcharapong Piyaphanee, et al.
Published: (2018) -
Differential regulation of IgG subclasses and IgE antimalarial antibody responses in complicated and uncomplicated Plasmodium falciparum malaria
by: P. Tangteerawatana, et al.
Published: (2018) -
Poor efficacy of antimalarial biguanide-dapsone combinations in the treatment of acute, uncomplicated, falciparum malaria in Thailand
by: P. Wilairatana, et al.
Published: (2018)